Skip to main content

The independent source for health policy research, polling, and news.

Subscribe Follow Us Donate
  • Trump 2.0

    Trump 2.0

    • Agency Watch
    • State Watch
    • Rural Health Payout
  • Public Health

    Public Health

    • Vaccines
    • CDC & Disease
    • Environmental Health
  • Audio Reports

    Audio Reports

    • What the Health?
    • Health Care Helpline
    • KFF Health News Minute
    • An Arm and a Leg
    • Health Hub
    • HealthQ
    • Silence in Sikeston
    • Epidemic
    • See All Audio
  • Special Reports

    Special Reports

    • Bill Of The Month
    • The Body Shops
    • Broken Rehab
    • Deadly Denials
    • Priced Out
    • Dead Zone
    • Diagnosis: Debt
    • Overpayment Outrage
    • Opioid Settlement Tracking
    • See All Special Reports
  • More Topics

    More Topics

    • Elections
    • Health Care Costs
    • Insurance
    • Prescription Drugs
    • Health Industry
    • Immigration
    • Reproductive Health
    • Technology
    • Rural Health
    • Race and Health
    • Aging
    • Mental Health
    • Affordable Care Act
    • Medicare
    • Medicaid
    • Children’s Health

  • GLP-1s for Medicare
  • Drug Control Strategy
  • Misoprostol
  • AI Deepfakes
  • Fruit-Flavored Vapes

WHAT'S NEW

  • GLP-1s for Medicare
  • Drug Control Strategy
  • Misoprostol
  • AI Deepfakes
  • Fruit-Flavored Vapes

Weekly Edition March 8, 2019

  • Email

Friday, Mar 15 2019

Hidden FDA Reports Detail Harm Caused By Scores Of Medical Devices

Christina Jewett and Heidi de Marco

The Food and Drug Administration has let medical device companies file reports of injuries and malfunctions outside a widely scrutinized public database, leaving doctors and medical sleuths in the dark.

Patients Question How FDA Approves Medical Devices

Blake Farmer, Nashville Public Radio

High-profile failures of implantable medical devices — such as certain hip joints and pelvic mesh — have prompted the Food and Drug Administration to revise its assessment process.

Cities And Counties Unlikely To Heed FDA Warning On Importing Foreign Drugs

Phil Galewitz

The Food and Drug Administration claims CanaRX, a company used by more than 500 cities, counties and school districts to help their employees get cheaper drugs from overseas, has sent “unapproved” and “misbranded” drugs to U.S. consumers, jeopardizing their safety.

Lawmakers United Against High Drug Prices Bare Partisan Teeth

Rachel Bluth

Clear differences of opinion emerged between Democrats and Republicans during a House Ways and Means subcommittee hearing about how to make prescription drugs more affordable in the Medicare program.

Big Pharma Gave Money To Patient Advocacy Groups Opposing Medicare Changes

Sydney Lupkin and Elizabeth Lucas and Victoria Knight

A KHN database shows that $58 million flowed from drugmakers to patient groups running national ads.

As Hospitals Post Price Lists, Consumers Are Asked To Check Up On Them

Steven Findlay

Most hospitals appear to be complying with the federal rule to post their prices online. Yet there is little follow-up by the government or industry and debate continues about whether the price lists are creating more confusion than clarity among consumers.

This Time When My Water Breaks, Take Me To A Hospital Without Surprise Bills

Rachel Bluth

New research shows how an experience with surprise medical bills can guide patients’ future decision-making.

A Mumps Quarantine In La. May Encroach On Rights Of Detained Immigrants

Shefali Luthra and Julie Appleby

A recent outbreak at a Louisiana center triggered public health protections, but some immigration lawyers are crying foul.

California Looks To Lead Nation In Unraveling Childhood Trauma

Anna Maria Barry-Jester

The Golden State, in a movement spearheaded by its first-ever surgeon general, stands to become a vanguard for the nation in tracing adverse childhood experiences, or ACEs, to the onset of physical and mental illness. But what can a pediatrician, with her 15-minute time slots and extensive to-do list, do about the ills of an absent parent or a neighborhood riddled with gun violence?

Patients Experiment With Prescription Drugs To Fight Aging

Marisa Taylor

Doctors and patients say they’re compelled to use off-label meds as research goes unfunded.

Always Connected With Thousands Of ‘Friends’ — Yet Feeling All Alone

Sharon Jayson

Millennials and Gen Zers say they often feel isolated even when surrounded by friends — both real and virtual.

Podcast: KHN’s ‘What The Health?’ What’s Next For The FDA?

Margot Sanger-Katz of The New York Times, Joanne Kenen of Politico and Kimberly Leonard of the Washington Examiner join KHN’s Julie Rovner to discuss the resignation of Food and Drug Administration Commissioner Scott Gottlieb, the latest on federal and state efforts to shore up the Affordable Care Act; and how public health officials plan to persuade parents who are reluctant to vaccinate their kids. Plus, for extra credit, the panelists recommend their favorite health policy stories of the week.

Recent Newsletters

  • The Week in Brief: Friday, May 1, 2026
  • Colorado Checkup: April 29, 2026
  • Rural Dispatch: Tuesday, April 28, 2026
  • The Week in Brief: Friday, April 24, 2026
  • The Week in Brief: Friday, April 17, 2026
  • The Week in Brief: Friday, April 10, 2026
More Newsletters
Newsletter icon

Sign Up For Our Newsletter

Stay informed by signing up for the Morning Briefing and other emails:

  • Podcasts
  • Special Reports
  • Morning Briefing
  • About Us
  • Donate
  • Staff
  • Republish Our Content
  • Contact Us

Follow Us

  • Instagram
  • YouTube
  • LinkedIn
  • Facebook
  • X
  • Bluesky
  • TikTok
  • RSS

Sign up for emails

Join our email list for regular updates based on your personal preferences.

Sign up
  • Editorial Policy
  • Privacy Policy

© 2026 KFF